US FDA To Explore New Regulatory Pathways For Some Cellular Products



CBER DIRECTOR PETER MARKS SAYS FDA PLANS TO EXPLORE WHETHER THERE IS AN INTERMEDIATE PATHWAY BETWEEN TISSUE REGULATIONS AND A FULL BLA FOR CERTAIN CELLULAR PRODUCTS. Source: Nielsen Hobbs; the Pink Sheet | Shutterstock, Getty images
https://pink.pharmaintelligence.informa.com/PS146208/US-FDA-To-Explore-New-Regulatory-Pathways-For-Some-Cellular-Products

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.